Expandable fluoropolymer device for delivery of therapeutic agents and method of making

• US 9,050,442 B2
• Filed: 06/22/2010
• Issued: 06/09/2015
• Est. Priority Date: 01/25/1999
• Status: Expired due to Fees

• Current Assignee: Atrium Medical Corporation (Getinge AB)
• Original Assignee: Atrium Medical Corporation (Getinge AB)
• Inventors: Herweck, Steve A., Gingras, Peter H., Martakos, Paul, Karwoski, Theodore
• Primary Examiner(s): SCHMIDT, EMILY LOUISE
• Application Number:
  US12/820,938
• Publication Number:
  US 20110118703A1
• Time in Patent Office: 1,813 Days
• Field of Search: 604/103.01, 604/103.06, 604/509
• US Class Current: 1/1
• CPC Class Codes: A61L 29/041 obtained by reactions only involving carbon-to-carbon unsaturated bonds
• CPC Class Codes: A61M 2025/0057 Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
• CPC Class Codes: A61M 2025/105 having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
• CPC Class Codes: A61M 2025/1075 having a balloon composed of several layers, e.g. by coating or embedding
• CPC Class Codes: A61M 25/10 Balloon catheters A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02; inflatable balloons for placing stents or stent-grafts A61F2/958 ; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00
• CPC Class Codes: A61M 25/1029 Production methods of the balloon members, e.g. blow-moulding, extruding, deposition or by wrapping a plurality of layers of balloon material around a mandril
• CPC Class Codes: B29C 2049/465 being incompressible
• CPC Class Codes: B29C 48/00 Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor extrusion blow-moulding B29C49/04
• CPC Class Codes: B29C 48/09 Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels
• CPC Class Codes: B29C 55/24 radial
• CPC Class Codes: B29K 2027/18 PTFE, i.e. polytetrafluorethene , e.g. ePTFE, i.e. expanded polytetrafluorethene
• CPC Class Codes: B29L 2022/022 Balloons
• CPC Class Codes: B29L 2031/753 Medical equipment; Accessories therefor bloodbags, medical bags B29L2031/7148; artificial eyes B29L2011/0008
• CPC Class Codes: B32B 2305/026 Porous
• CPC Class Codes: C08L 27/18 Homopolymers or copolymers or tetrafluoroethene

Abstract

A method of making a radially expandable fluid delivery device includes providing a tube of biocompatible fluoropolymer material with a predetermined porosity based on an extrusion and expansion forming process, applying a radial expansion force to the tube expanding the tube to a predetermined diameter dimension, and removing the radial expansion force. The tube is radially inelastic while sufficiently pliable to be collapsible and inflatable from a collapsed configuration to an expanded configuration upon introduction of an inflation force, such that the expanded configuration occurs upon inflation to the predetermined diameter dimension. The fluid delivery device is constructed of a microporous, biocompatible fluoropolymer material having a microstructure that can provide a controlled, uniform, low-velocity fluid distribution through the walls of the fluid delivery device to effectively deliver fluid to the treatment site without damaging tissue proximate the walls of the device.

Claims

1. A method of using a radially expandable fluid delivery device for delivery of one or more therapeutic agents, comprising:

locating the radially expandable fluid delivery device within a body passage in need of treatment, the radially expandable fluid delivery device formed of a radially inelastic wall having at least one microporous portion formed of a microstructure of nodes interconnected by fibrils having spaces therebetween forming generally aligned micro-channels having a porosity sufficient to cause a fluid containing the one or more therapeutic agents and supplied thereto to provide a radial deployment force to expand the fluid delivery device and to permeate through the micro-channels, the micro-channels substantially controlling the permeation of the fluid from a location interior to the wall to a location exterior to the wall by passing through the wall; and

expanding the radially expandable fluid delivery device using a radial deployment force supplied by the fluid containing the one or more therapeutic agents in such a way that the radially expandable fluid delivery device expands and occludes the body passage and the fluid containing the one or more therapeutic agents flows from the location interior to the wall to the location exterior to the wall by flowing through the wall of the radially expandable fluid delivery device thereby delivering the one or more therapeutic agents to the body passage while also applying the radial deployment force.

2. The method of claim 1, wherein the radially expandable fluid delivery device is made of biocompatible material, and wherein the radially inelastic wall is unitary and seamless.

3. The method of claim 1, wherein the nodes are separated by an internodal distance of about 1 μ

m to 150 μ

m.

4. The method of claim 1, wherein expanding the radially expandable fluid delivery device comprises providing the fluid at a pressure of between about 1 psi to 250 psi.

5. The method of claim 1, wherein the wall of the radially expandable fluid delivery device has a porosity sufficient to allow fluid to pass therethrough at a flow rate of about 0.01 ml/min to 100 ml/min.

6. The method of claim 1, wherein the one or more therapeutic agents comprise thrombolytics, antibiotics, antisense oligonucleotides, chemotherapeutics, surfactants, diagnostic agents, steroids, vasodilators, vasoconstrictors, or embolic agents.

7. The method of claim 1, wherein the one or more therapeutic agents comprise heparin and/or urokinase.

8. The method of claim 1, wherein expanding the radially expandable fluid delivery device and delivering the one or more therapeutic agents occurs simultaneously and by a single radially expandable fluid delivery device.

9. The method of claim 1, wherein delivering the one or more therapeutic agents occurs in such a way as to reduce the volume of the one or more therapeutic agents delivered to a periphery of the body passage in need of treatment to minimize damage to healthy tissue located away from the body passage in need of treatment.

10. The method of claim 1, wherein delivering the one or more therapeutic agents occurs in such a way as to deliver relatively high concentrations of the one or more therapeutic agents to localized areas of the body passage in need of treatment.

11. The method of claim 1, wherein delivering the one or more therapeutic agents occurs using relatively high concentrations of the one or more therapeutic agents to localized areas of the body passage in need of treatment in such a way as to increase effectiveness of the one or more therapeutic agents and negate systemic side effects from the one or more therapeutic agents.

12. A method of using a radially expandable fluid delivery device for delivery of one or more therapeutic agents, comprising:

locating the radially expandable fluid delivery device at a body location, the radially expandable fluid delivery device formed of a radially inelastic wall having at least one microporous portion formed of a microstructure of nodes interconnected by fibrils having spaces therebetween forming generally aligned micro-channels having a porosity sufficient to cause a fluid containing the one or more therapeutic agents and supplied thereto to provide a radial deployment force to expand the fluid delivery device and to permeate through the micro-channels, the micro-channels substantially controlling the permeation of the fluid through the wall, the method; and

expanding the radially expandable fluid delivery device using a radial deployment force supplied by the fluid containing the one or more therapeutic agents in such a way that the fluid containing the one or more therapeutic agents flows from a location interior to the wall to a location exterior to the wall by flowing through the wall of the radially expandable fluid delivery device thereby delivering the one or more therapeutic agents to the body location.

13. The method of claim 12, wherein the body location comprises multiple sites within the body that are treated.

14. The method of claim 12, wherein the radially expandable fluid delivery device is made of biocompatible material, and wherein the radially inelastic wall is unitary and seamless.

15. The method of claim 12, wherein the nodes are separated by an internodal distance of about 1 μ

m to 150 μ

m.

16. The method of claim 12, wherein expanding the radially expandable fluid delivery device comprises providing the fluid at a pressure of between about 1 psi to 250 psi.

17. The method of claim 12, wherein the wall of the radially expandable fluid delivery device has a porosity sufficient to allow fluid to pass therethrough at a flow rate of about 0.01 ml/min to 100 ml/min.

18. The method of claim 12, wherein the one or more therapeutic agents comprise thrombolytics, antibiotics, antisense oligonucleotides, chemotherapeutics, surfactants, diagnostic agents, steroids, vasodilators, vasoconstrictors, or embolic agents.

19. The method of claim 12, wherein the one or more therapeutic agents comprise heparin and/or urokinase.

20. The method of claim 12, wherein expanding the radially expandable fluid delivery device and delivering the one or more therapeutic agents occurs simultaneously and by a single radially expandable fluid delivery device.

21. The method of claim 12, wherein delivering the one or more therapeutic agents occurs in such a way as to reduce the volume of the one or more therapeutic agents delivered to a periphery of the body location to minimize damage to healthy tissue located away from the body location.

22. The method of claim 12, wherein delivering the one or more therapeutic agents occurs in such a way as to deliver relatively high concentrations of the one or more therapeutic agents to localized areas of the body location.

23. The method of claim 12, wherein delivering the one or more therapeutic agents occurs using relatively high concentrations of the one or more therapeutic agents to localized areas of the body location in such a way as to increase effectiveness of the one or more therapeutic agents and negate systemic side effects from the one or more therapeutic agents.

24. A method of using a radially expandable fluid delivery device for delivery of one or more therapeutic agents, comprising:

locating the radially expandable fluid delivery device within a body passage in need of treatment, the radially expandable fluid delivery device formed of a unitary, seamless and radially inelastic wall comprised of an expanded fluoropolymer, the radially inelastic wall constructed to be tubular and having a distal portion and a proximal portion, the wall having at least one microporous portion formed of a microstructure of nodes interconnected by fibrils having spaces therebetween forming generally aligned micro-channels having a porosity sufficient to cause a fluid containing the one or more therapeutic agents and supplied thereto to provide a radial deployment force to expand the fluid delivery device and to permeate through the micro-channels, the micro-channels substantially controlling the permeation of the fluid outwardly from a location interior to the radially inelastic wall to a location exterior to the radially inelastic wall by passing through the radially inelastic wall, the radially expandable fluid delivery device further comprising a catheter having a sidewall and extending from a proximal end of the radially inelastic wall to a distal end of the radially inelastic wall, at least one aperture in the catheter'"'"'s sidewall for establishing fluid communication between the catheter and the location interior to the radially inelastic wall; and

expanding the radially expandable fluid delivery device using a radial deployment force supplied by the fluid containing the one or more therapeutic agents in such a way that the radially expandable fluid delivery device expands and occludes the body passage and the fluid containing the one or more therapeutic agents flows from the location interior to the wall to the location exterior to the wall by flowing through the radially inelastic wall of the radially expandable fluid delivery device thereby delivering the one or more therapeutic agents to the body passage while also applying the radial deployment force.